Lixin Wei

10PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursImmunogenetics (incl. genetic immunology)Condensed matter physics not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 21, 2025
Lipopolysaccharide Induces Resistance to CAR-T Cell Therapy of Colorectal Cancer Cells through TGF-β-Mediated Stemness Enhancement.

Min Tao, Mengmeng Xue, Daoyu Zhou

|Jan 18, 2025
ERG mediates the differentiation of hepatic progenitor cells towards immunosuppressive PDGFRα<sup>+</sup> cancer-associated fibroblasts during hepatocarcinogenesis.

Haoran Bai, Xinyu Zhu, Lu Gao

|Aug 15, 2024
HDAC2 promotes autophagy-associated HCC malignant progression by transcriptionally activating LAPTM4B.

Meifeng Wang, Jianping Liao, Jie Wang

|Nov 27, 2023
GPNMB<sup>+</sup> Gal-3<sup>+</sup> hepatic parenchymal cells promote immunosuppression and hepatocellular carcinogenesis.

Yan Meng, Qiudong Zhao, Yan Sang

|Aug 06, 2023
Hippo Pathway Activation in Aged Mesenchymal Stem Cells Contributes to the Dysregulation of Hepatic Inflammation in Aged Mice.

Xue Yang, Chen Zong, Chao Feng

|Sep 28, 2022
Reply: Questioning the existence of Aif1+ , Csf1r+ mesenchymal stem cells.

Chen Zong, Yan Meng, Lixin Wei

Pageof 2

Frequent Collaborators

1 joint publications

Yiming Hu

1 joint publications

Yan Meng

1 joint publications

Qiudong Zhao

1 joint publications

Yan Sang